Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Cellectis s.a. symbols : Nvs save search
Gene Editing Technologies Global Market to 2032: Introduction of New Technologies Fuelling the Growth of Gene Editing Technologies
Published: 2023-06-02 (Crawled : 17:00) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
TMO | News | $542.43 -0.88% 810K
|
Health Technology
|
| O: 1.0%
H: 0.49%
C: -0.85%
NVS | News | $92.61 -0.51% 430K
|
Health Technology
|
| O: 1.03%
H: 0.84%
C: 0.82%
DHR | $237.72 -0.7% 1.4M
|
Health Technology
|
| O: 0.8%
H: 0.55%
C: 0.03%
SGMO | $0.5115 -0.87% 620K
|
Health Technology
|
| O: 1.8%
H: 2.65%
C: 1.77%
DTIL | $11.41 -0.87% 30K
|
Health Technology
|
| O: 1.69%
H: 1.27%
C: -3.85%
IONS | $41.49 1.42% 120K
|
Health Technology
|
| O: 0.75%
H: 0.32%
C: -3.49%
NTLA | $21.61 0.51% 250K
|
Health Technology
|
| O: 1.89%
H: 5.61%
C: 5.35%
CRSP M | $56.355 1.43% 300K
|
Health Technology
|
| O: 1.32%
H: 0.84%
C: -0.57%
CLLS | $2.46 2.6K
|
Health Technology
|
| O: 1.02%
H: 0.5%
C: 0.0%
global growth market technology
Global Gene Therapy Market Research Report 2022-2031 Featuring Major Players - Novartis AG; Bluebird bio, Inc.; Spark Therapeutics, Inc; Audentes Therapeutics; Voyager Therapeutics
Published: 2022-06-20 (Crawled : 12:00) - prnewswire.com
SNY | News | $45.56 -1.19% 910K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 1.4K
|
Health Technology
| Email alert
Add to watchlist
QURE | $4.7 0.64% 150K
|
Health Technology
| Email alert
Add to watchlist
CLLS | $2.46 2.6K
|
Health Technology
| Email alert
Add to watchlist
SRPT | $118.32 0.37% 65K
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
AGTC | $0.3936 1.23% 0.0%
|
Health Technology
| Email alert
Add to watchlist
BLUE | $0.9616 -0.18% 1.9M
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $92.61 -0.51% 430K
|
Health Technology
| Email alert
Add to watchlist
research report novartis therapeutics therapy market
Excision BioTherapeutics Expands Management Team with Three Key Appointments
Published: 2021-10-12 (Crawled : 13:15) - biospace.com/
SYK | $331.43 -1.37% 430K
|
Health Technology
|
| O: 0.47%
H: 0.13%
C: -0.68%
NVS | News | $92.61 -0.51% 430K
|
Health Technology
|
| O: -0.11%
H: 0.34%
C: -0.33%
JNJ | News | $144.86 0.06% 2.8M
|
Health Technology
|
| O: -0.16%
H: 0.11%
C: -1.44%
RCKT M | $23.61 -0.3% 94K
|
Health Technology
|
| O: 1.3%
H: 0.9%
C: 0.31%
CLLS | $2.46 2.6K
|
Health Technology
|
| O: 1.33%
H: 2.18%
C: 0.0%
iot
Global Gene Therapy Markets Report 2021-2030: Antigen, Cytokine, Suicide Gene, Viral Vector, Non-Viral Vector, Oncological, Rare Diseases, Cardiovascular, Neurological Disorders, Infectious Diseases
Published: 2021-06-25 (Crawled : 11:00) - prnewswire.com
NVS | News | $92.61 -0.51% 430K
|
Health Technology
|
| O: 0.16%
H: 0.09%
C: -0.13%
QURE | $4.7 0.64% 150K
|
Health Technology
|
| O: 0.73%
H: 2.08%
C: 2.01%
SRPT | $118.32 0.37% 65K
|
Health Technology
|
| O: 0.15%
H: 1.37%
C: 0.75%
SNY | News | $45.56 -1.19% 910K
|
Health Technology
|
| O: 0.55%
H: 0.68%
C: 0.57%
CLLS | $2.46 2.6K
|
Health Technology
|
| O: -0.45%
H: 1.88%
C: 1.3%
BLUE | $0.9616 -0.18% 1.9M
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: -4.89%
AGTC | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: -1.97%
H: 0.24%
C: -2.72%
disease neurological cardiovascular infectious disease gene therapy therapy cardio gene therapies rare
Gainers vs Losers
| 82% | 18% |
Top 10 Gainers
AGBA | $0.7995 99.88% 73M
|
Finance
BPTH | $6.21 91.67% 58M
|
Health Technology
INVO | $1.36 78.95% 3.6M
|
Health Technology
TIRX | $0.8258 70.34% 50M
|
ISPC | $0.307 44.13% 3.6M
|
Professional, Scientific, and T...
SINT | $0.0519 39.14% 350M
|
Health Technology
VTNR S | $1.295 32.25% 5.5M
|
Industrial Services
ALRN | $5.53 30.12% 250K
|
Health Technology
SMSI 4 | $2.53 29.74% 510K
|
Technology Services
HOLO | $2.86 27.68% 28M
|
Your saved searches
Save your searches and get alerts when important news are released.